Last year, AliveCor, a maker of personal electrocardiogram (ECG) technology, filed two lawsuits against Apple, accusing them of infringing on their patent with the Apple Watch and engaging in anti-competition practices.
If the final decision goes in their favor, Apple could be prohibited from importing Apple Watches in the US.
On June 27, AliveCore shared that an administrative law judge from the International Trade Commission has issued an initial determination. In it, he agreed that Apple’s ECG from the Apple Watch does indeed infringe on a patent owned by AliveCor.
“Today’s ruling is a strong validation of our IP and underscores that patents matter and even an influential company like Apple cannot simply violate them to stifle innovation.
Since the start, our focus has been on our customers and providing them with strong choices to help monitor their cardiac health, including KardiaBand, the first-ever FDA-cleared ECG device accessory for Apple Watch,” said Priya Abani, CEO of AliveCor, in the press release.
The final determination for this trial was scheduled by the ITC for October 26. If the judges rule against Apple, AliveCor says that the infringing Apple Watches could face an exclusion order that will prohibit Apple from importing them into the US.